Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Schubert

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Aging|February 7, 2021
Geroprotective effects of Alzheimer's disease drug candidatesDevin Kepchia, Antonio Currais, Richard Dargusch, et al.
Journal of Neurochemistry|December 18, 2002
Transient modulation of cytoplasmic and nuclear retinoid receptors expression in differentiating human teratocarcinoma NT2 cellsRoberta Borghi, Roberta Venè, Giuseppe Arena, et al.
Molecular Neurobiology|May 20, 2019
Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer's DiseaseDavid Schubert, Devin Kepchia, Zhibin Liang, et al.
Alzheimer'S Research & Therapy|July 16, 2017
A novel Alzheimer's disease drug candidate targeting inflammation and fatty acid metabolismDaniel Daugherty, Joshua Goldberg, Wolfgang Fischer, et al.
Aging Cell|September 4, 2012
Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated miceAntonio Currais, Marguerite Prior, David Lo, et al.
Trends in Pharmacological Sciences|November 18, 2018
Geroneuroprotectors: Effective Geroprotectors for the BrainDavid Schubert, Antonio Currais, Joshua Goldberg, et al.
NPJ Aging and Mechanisms of Disease|July 20, 2017
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoidsAntonio Currais, Oswald Quehenberger, Aaron M Armando, et al.
International Journal of Molecular Sciences|April 13, 2023
The Geroprotective Drug Candidate CMS121 Alleviates Diabetes, Liver Inflammation, and Renal Damage in db/db Leptin Receptor Deficient MiceSaadia Zahid, Alcir L Dafre, Antonio Currais, et al.
The American Journal of Hospice & Palliative Care|March 10, 2017
Earlier Goals of Care Discussions in Hospitalized Terminally Ill Patients and the Quality of End-of-Life Care: A Retrospective StudyMarzena Gieniusz, Rosane Nunes, Valerie Saha, et al.
Plos One|July 9, 2011
Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetesPamela Maher, Richard Dargusch, Jennifer L Ehren, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Aging|February 7, 2021
Geroprotective effects of Alzheimer's disease drug candidatesDevin Kepchia, Antonio Currais, Richard Dargusch, et al.
Journal of Neurochemistry|December 18, 2002
Transient modulation of cytoplasmic and nuclear retinoid receptors expression in differentiating human teratocarcinoma NT2 cellsRoberta Borghi, Roberta Venè, Giuseppe Arena, et al.
Molecular Neurobiology|May 20, 2019
Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer's DiseaseDavid Schubert, Devin Kepchia, Zhibin Liang, et al.
Alzheimer'S Research & Therapy|July 16, 2017
A novel Alzheimer's disease drug candidate targeting inflammation and fatty acid metabolismDaniel Daugherty, Joshua Goldberg, Wolfgang Fischer, et al.
Aging Cell|September 4, 2012
Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated miceAntonio Currais, Marguerite Prior, David Lo, et al.
Trends in Pharmacological Sciences|November 18, 2018
Geroneuroprotectors: Effective Geroprotectors for the BrainDavid Schubert, Antonio Currais, Joshua Goldberg, et al.
NPJ Aging and Mechanisms of Disease|July 20, 2017
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoidsAntonio Currais, Oswald Quehenberger, Aaron M Armando, et al.
International Journal of Molecular Sciences|April 13, 2023
The Geroprotective Drug Candidate CMS121 Alleviates Diabetes, Liver Inflammation, and Renal Damage in db/db Leptin Receptor Deficient MiceSaadia Zahid, Alcir L Dafre, Antonio Currais, et al.
The American Journal of Hospice & Palliative Care|March 10, 2017
Earlier Goals of Care Discussions in Hospitalized Terminally Ill Patients and the Quality of End-of-Life Care: A Retrospective StudyMarzena Gieniusz, Rosane Nunes, Valerie Saha, et al.
Plos One|July 9, 2011
Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetesPamela Maher, Richard Dargusch, Jennifer L Ehren, et al.
Pageof 9